Soleno Therapeutics Inc (SLNO)
48.08
+1.82
(+3.93%)
USD |
NASDAQ |
May 09, 14:37
Soleno Therapeutics Cash from Operations (TTM): -24.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -24.94M |
September 30, 2023 | -23.77M |
June 30, 2023 | -22.09M |
March 31, 2023 | -21.15M |
December 31, 2022 | -20.78M |
September 30, 2022 | -22.50M |
June 30, 2022 | -23.25M |
March 31, 2022 | -26.64M |
December 31, 2021 | -27.77M |
September 30, 2021 | -27.77M |
June 30, 2021 | -28.53M |
March 31, 2021 | -27.05M |
December 31, 2020 | -25.22M |
September 30, 2020 | -23.43M |
June 30, 2020 | -21.99M |
March 31, 2020 | -19.35M |
December 31, 2019 | -17.38M |
September 30, 2019 | -16.04M |
June 30, 2019 | -13.99M |
March 31, 2019 | -12.85M |
December 31, 2018 | -11.68M |
Date | Value |
---|---|
September 30, 2018 | -10.68M |
June 30, 2018 | -10.04M |
March 31, 2018 | -10.29M |
December 31, 2017 | -9.95M |
September 30, 2017 | -9.907M |
June 30, 2017 | -10.65M |
March 31, 2017 | -11.70M |
December 31, 2016 | -13.50M |
September 30, 2016 | -14.19M |
June 30, 2016 | -14.26M |
March 31, 2016 | -12.47M |
December 31, 2015 | -10.30M |
September 30, 2015 | -8.477M |
June 30, 2015 | -6.878M |
March 31, 2015 | -5.784M |
December 31, 2014 | -4.484M |
September 30, 2014 | -3.650M |
June 30, 2014 | -3.312M |
March 31, 2014 | -3.479M |
December 31, 2013 | -0.8852M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.53M
Minimum
Jun 2021
-13.99M
Maximum
Jun 2019
-22.82M
Average
-23.25M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
Avid Bioservices Inc | 12.68M |
United Therapeutics Corp | 979.70M |
Creative Medical Technology Holdings Inc | -8.028M |
Viking Therapeutics Inc | -54.87M |
Avenue Therapeutics Inc | -9.451M |